DOI: 10.4244/EIJV9I9A189

What embolises to the brain during transcatheter aortic valve implantation?

Nicolas M. Van Mieghem1*, MD; Marguerite E.I. Schipper2, MD; Peter P. de Jaegere1, MD, PhD

An 83-year-old female patient underwent a transcatheter aortic valve implantation (TAVI) for symptomatic severe aortic stenosis with a high operative risk (logistic EuroSCORE 45%). The procedure was performed using the Montage™ Dual Filter embolic protection device (EPD) (Claret Medical, Inc., Santa Rosa, CA, USA), inserted through a right radial artery and encompassing the deployment of a proximal filter basket in the brachiocephalic trunk and a distal filter basket in the left common carotid artery (Figure 1A and Figure 1B). The procedure evolved uneventfully with successful deployment of a 29 mm Medtronic CoreValve™ (Medtronic Inc., Minneapolis, MN, USA) (Figure 1C). The EPD was then retrieved and contained a mixture of red and white material (with sizes varying from 1.5 to 7.1 mm) (Figure 1D). Figure 1E illustrates microscopic (magnification 2x) overview of two different fragments after haematoxylin & eosin (H&E) staining with material resembling tissue (*) and thrombus (**). Further analysis (magnification 20x) of the tissue fragment (Figure 1F) shows spindle-shaped fibroblasts with small purple nuclei and vacuolated proteoglycan-rich cytoplasm (light blue) partly covered by remnants of endothelial lining. These features can stem from large elastic arteries but seem more compatible with aortic valve leaflet origin given the absence of atherosclerosis or other typical hallmarks of vessel structures and bearing in mind the aortic root instrumentation during TAVI. Figure 1G (magnification 20x) demonstrates fibrin material (dark pink) mixed with clusters of platelets (blue), white blood cells (purple) and erythrocytes (red) and represents typical thrombus formation. Further research is warranted to assess whether the use of embolic protection devices will reduce the incidence of TAVI-related cerebrovascular embolisation and procedural stroke.

Figure 1. Transcatheter aortic valve implantation under cerebral embolic protection with the Montage Dual Filter and analysis of captured debris.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 9 Number 9
Jan 20, 2014
Volume 9 Number 9
View full issue


Key metrics

Suggested by Cory

Research Correspondence

10.4244/EIJ-D-23-00743 Feb 19, 2024
Final report of the PROTEMBO C Trial: a prospective evaluation of a novel cerebral protection device during TAVI
Fezzi S et al
free

Clinical research

10.4244/EIJ-D-23-00465 Dec 18, 2023
First-in-human study of the CAPTIS embolic protection system during transcatheter aortic valve replacement
Danenberg H et al
free

EXPERT REVIEW

10.4244/EIJ-D-18-00454 Sep 7, 2018
TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy
Lansky AJ et al
free
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
34.8

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
26.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
26.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
23.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved